Keywords: glaxo, wellcome, profits, take, slight, tumble, sales
Glaxo Wellcome 1999 profits take a slight tumble, as sales rise just 5%
Article | 17 February 2000
Glaxo Wellcome has announced a sales rise of just 6% for 1999, reachingL8.49 billion ($13.48 billion), while pretax profits fell slightly to L2.57 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
